Cargando…

Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso

(1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaboré, Jean Moïse Tanga, Siribié, Mohamadou, Hien, Denise, Soulama, Issiaka, Barry, Nouhoun, Baguiya, Adama, Tiono, Alfred B., Burri, Christian, Tchouatieu, André-Marie, Sirima, Sodiomon B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145444/
https://www.ncbi.nlm.nih.gov/pubmed/37104321
http://dx.doi.org/10.3390/tropicalmed8040195
_version_ 1785034334878564352
author Kaboré, Jean Moïse Tanga
Siribié, Mohamadou
Hien, Denise
Soulama, Issiaka
Barry, Nouhoun
Baguiya, Adama
Tiono, Alfred B.
Burri, Christian
Tchouatieu, André-Marie
Sirima, Sodiomon B.
author_facet Kaboré, Jean Moïse Tanga
Siribié, Mohamadou
Hien, Denise
Soulama, Issiaka
Barry, Nouhoun
Baguiya, Adama
Tiono, Alfred B.
Burri, Christian
Tchouatieu, André-Marie
Sirima, Sodiomon B.
author_sort Kaboré, Jean Moïse Tanga
collection PubMed
description (1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying multiple first-line therapies (MFT) may help mitigate this threat and extend the therapeutic life of current ACTs. (2) Methods: A district-wide pilot quasi-experimental study was conducted, deploying three different ACTs at the public health facility (PHF) level for uncomplicated malaria treatment from December 2019 to December 2020 in the health district (HD) of Kaya, Burkina Faso. Mixed methods, including household and health facility-based quantitative and qualitative surveys, were used to evaluate the pilot programme. (3) Results: A total of 2008 suspected malaria patients were surveyed at PHFs, of which 79.1% were tested by rapid diagnostic test (RDT) with 65.5% positivity rate. In total, 86.1% of the confirmed cases received the appropriate ACT according to the MFT strategy. The adherence level did not differ by study segment (p = 0.19). Overall, the compliance level of health workers (HWs) with MFT strategy was 72.7% (95% CI: 69.7–75.5). The odds of using PHF as the first source of care increased after the intervention (aOR = 1.6; 95% CI, 1.3–1.9), and the reported adherence to the 3-day treatment regimen was 82.1%; (95% CI: 79.6–84.3). Qualitative results showed a high acceptance of the MFT strategy with positive opinions from all stakeholders. (4) Conclusions: Implementing an MFT strategy is operationally feasible and acceptable by stakeholders in the health systems in Burkina Faso. This study provides evidence to support the simultaneous use of multiple first-line artemisinin combination therapies in malaria-endemic countries such as Burkina Faso.
format Online
Article
Text
id pubmed-10145444
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101454442023-04-29 Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso Kaboré, Jean Moïse Tanga Siribié, Mohamadou Hien, Denise Soulama, Issiaka Barry, Nouhoun Baguiya, Adama Tiono, Alfred B. Burri, Christian Tchouatieu, André-Marie Sirima, Sodiomon B. Trop Med Infect Dis Article (1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying multiple first-line therapies (MFT) may help mitigate this threat and extend the therapeutic life of current ACTs. (2) Methods: A district-wide pilot quasi-experimental study was conducted, deploying three different ACTs at the public health facility (PHF) level for uncomplicated malaria treatment from December 2019 to December 2020 in the health district (HD) of Kaya, Burkina Faso. Mixed methods, including household and health facility-based quantitative and qualitative surveys, were used to evaluate the pilot programme. (3) Results: A total of 2008 suspected malaria patients were surveyed at PHFs, of which 79.1% were tested by rapid diagnostic test (RDT) with 65.5% positivity rate. In total, 86.1% of the confirmed cases received the appropriate ACT according to the MFT strategy. The adherence level did not differ by study segment (p = 0.19). Overall, the compliance level of health workers (HWs) with MFT strategy was 72.7% (95% CI: 69.7–75.5). The odds of using PHF as the first source of care increased after the intervention (aOR = 1.6; 95% CI, 1.3–1.9), and the reported adherence to the 3-day treatment regimen was 82.1%; (95% CI: 79.6–84.3). Qualitative results showed a high acceptance of the MFT strategy with positive opinions from all stakeholders. (4) Conclusions: Implementing an MFT strategy is operationally feasible and acceptable by stakeholders in the health systems in Burkina Faso. This study provides evidence to support the simultaneous use of multiple first-line artemisinin combination therapies in malaria-endemic countries such as Burkina Faso. MDPI 2023-03-28 /pmc/articles/PMC10145444/ /pubmed/37104321 http://dx.doi.org/10.3390/tropicalmed8040195 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kaboré, Jean Moïse Tanga
Siribié, Mohamadou
Hien, Denise
Soulama, Issiaka
Barry, Nouhoun
Baguiya, Adama
Tiono, Alfred B.
Burri, Christian
Tchouatieu, André-Marie
Sirima, Sodiomon B.
Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
title Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
title_full Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
title_fullStr Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
title_full_unstemmed Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
title_short Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
title_sort feasibility and acceptability of a strategy deploying multiple first-line artemisinin-based combination therapies for uncomplicated malaria in the health district of kaya, burkina faso
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145444/
https://www.ncbi.nlm.nih.gov/pubmed/37104321
http://dx.doi.org/10.3390/tropicalmed8040195
work_keys_str_mv AT kaborejeanmoisetanga feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT siribiemohamadou feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT hiendenise feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT soulamaissiaka feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT barrynouhoun feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT baguiyaadama feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT tionoalfredb feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT burrichristian feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT tchouatieuandremarie feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso
AT sirimasodiomonb feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso